Demography of patients randomised in group A, assigned to CBS treatment, and group B, assigned to PBS treatment. Info on previous systemic or topical treatments is also given
| Group | A | B |
| Treatment | CBS | PBS |
| Females | 24 | 20 |
| Age* | 65.5 (61.5–69.0) | 66.5 (61.3–70.0) |
| Males | 7 | 9 |
| Age* | 52.0 (45.0–71.5) | 53.0 (43.0–68.3) |
| Rheumatoid arthritis (n) | 5 | 2 |
| Sjogren’s syndrome (n) | 9 | 7 |
| GVHD (n) | 9 | 8 |
| Systemic treatments (steroids) | 7 | 5 |
| Systemic treatments (cyclosporine) | 3 | 4 |
| Topical treatments | 30 | 30 |
| Previous serum | 4 | 3 |
| Steroids | 12 | 14 |
| Cyclosporine | 2 | 2 |
| Tear substitutes only | 20 | 18 |
| Tear substitutes plus gel | 6 | 8 |
| Tear substitutes plus ointment | 4 | 4 |
*Years, median (95% CI).
CBS, cord blood serum; PBS, pheripheral blood serum.